These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3683093)

  • 1. Cyanamide hepatotoxicity. Incidence and clinico-pathological features.
    Bruguera M; Parés A; Heredia D; Rodés J
    Liver; 1987 Aug; 7(4):216-22. PubMed ID: 3683093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic disease associated with ground-glass inclusions in hepatocytes after cyanamide therapy.
    Bruguera M; Lamar C; Bernet M; Rodés J
    Arch Pathol Lab Med; 1986 Oct; 110(10):906-10. PubMed ID: 3021086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyanamide-induced liver dysfunction after abstinence in alcoholics: a long-term follow-up study on four cases.
    Suzuki Y; Yokoyama A; Nakano M; Okuyama K; Takahashi H; Tamai H; Maruyama K; Ishii H
    Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):100S-105S. PubMed ID: 10803790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cyanamide and disulfiram in effects on liver function.
    Tamai H; Yokoyama A; Okuyama K; Takahashi H; Maruyama K; Suzuki Y; Ishii H
    Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):97S-99S. PubMed ID: 10803789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis induced by drugs used as alcohol aversion therapy.
    Vázquez JJ; Diaz de Otazu R; Guillen FJ; Zozaya J; Pardo FJ
    Diagn Histopathol; 1983; 6(1):29-37. PubMed ID: 6307616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyanamide-induced liver injury in alcoholics.
    Vázquez JJ; Cervera S
    Lancet; 1980 Feb; 1(8164):361-2. PubMed ID: 6101808
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyanamide-induced liver injury. A predictable lesion.
    Vazquez JJ; Guillen FJ; Zozaya J; Lahoz M
    Liver; 1983 Aug; 3(4):225-30. PubMed ID: 6323909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyanamide-associated alcoholic liver disease: a sequential histological evaluation.
    Yokoyama A; Sato S; Maruyama K; Nakano M; Takahashi H; Okuyama K; Takagi S; Takagi T; Yokoyama T; Hayashida M
    Alcohol Clin Exp Res; 1995 Oct; 19(5):1307-11. PubMed ID: 8561306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatotoxicity induced by cyanamide. A review of the anatomicopathological changes apropos a case].
    Román Llorente FJ; Iglesias García E; Fojón Polanco S; Mariño Callejo A; Pia Iglesias G; Gordo Fraile P
    An Med Interna; 1989 Nov; 6(11):589-90. PubMed ID: 2562702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural hepatic changes associated with cyanamide treatment: cholangiolar proliferation, fibrosis and cirrhosis.
    Moreno A; Vazquez JJ; Ruizdel Arbol L; Guillen FJ; Colina F
    Liver; 1984 Feb; 4(1):15-21. PubMed ID: 6321877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Liver lesion caused by cyanamide. Study of a case and review of the bibliography].
    Sáenz de Santa María J; Moreno Casado J; Sánchez Satrústegui JF
    Rev Esp Enferm Apar Dig; 1988 Apr; 73(4):417-20. PubMed ID: 3291022
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cyanamide hepatotoxicity: various forms of presentation. Apropos of 2 cases].
    Caballería Rovira E; Aragó López JV; Massó Ubeda RM; Vidal Clemente JL; Sanchís Closa A
    Rev Clin Esp; 1986 Jun; 179(2):79-81. PubMed ID: 2942986
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of a monoclonal antibody against Lafora bodies for the immunocytochemical study of ground-glass inclusions in hepatocytes due to cyanamide.
    Hashimoto K; Hoshii Y; Takahashi M; Mitsuno S; Hanai N; Watanabe Y; Ishihara T
    Histopathology; 2001 Jul; 39(1):60-5. PubMed ID: 11454045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Liver function in alcoholic patients treated with cyanamide].
    Borja Villegas J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984; 12(3):223-5. PubMed ID: 6485916
    [No Abstract]   [Full Text] [Related]  

  • 15. Ground glass inclusions in liver cells in an alcoholic treated with cyanamide (Dipsan).
    Thomsen P; Reinicke V
    Liver; 1981 Mar; 1(1):67-73. PubMed ID: 6294436
    [No Abstract]   [Full Text] [Related]  

  • 16. A review of the clinical use of disulfiram and calcium carbimide in alcoholism treatment.
    Peachey JE
    J Clin Psychopharmacol; 1981 Nov; 1(6):368-75. PubMed ID: 7037876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The disulfiram and calcium carbimide acetaldehyde-mediated ethanol reactions.
    Peachey JE; Sellers EM
    Pharmacol Ther; 1981; 15(1):89-97. PubMed ID: 7038717
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cyanamide hepatotoxicity: various forms of presentation. Apropos of 2 cases].
    Vázquez JJ
    Rev Clin Esp; 1987 May; 180(8):466-7. PubMed ID: 3616033
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse hepatic reactions associated with calcium carbimide and disulfiram therapy: is there still a role for these drugs?
    Verge C; Lucena MI; López-Torres E; Puche-Garcia MJ; Fraga E; Romero-Gomez M; Andrade RJ
    World J Gastroenterol; 2006 Aug; 12(31):5078-80. PubMed ID: 16937512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of calcium carbimide after failure of disulfiram to cause a reaction to alcohol.
    Brewer C
    Lancet; 1984 Jul; 2(8395):171. PubMed ID: 6146072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.